R. Douglas Norby Net Worth & Insider Trades
R. Douglas Norby - Director, Krystal Biotech, Inc
What is R. Douglas Norby's Net Worth?
The current estimated net worth of Krystal Biotech, Inc's Director, R. Douglas Norby, is estimated to be about $24.69M . R. Douglas Norby owns about 9,000 units of Krystal Biotech, Inc common stock. In the last month at Krystal Biotech, Inc, R. Douglas Norby has sold an estimated value of $0 worth.
What is R. Douglas Norby's Past Insider Trading?
R. Douglas Norby's largest purchase order was 9,000 units , worth over $93.78K on May 11, 2018. In total, R. Douglas Norby has made about 2 transactions over a month of their time at Krystal Biotech, Inc. R. Douglas Norby usually trades in May and June, with the busiest year in 2018.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
R. Douglas Norby
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
InsideArbitrage
What was R. Douglas Norby's Salary in 2020?
As Director of Krystal Biotech, Inc, R. Douglas Norby has a total base salary of $190,580 . R. Douglas Norby received compensation valued at about $1,911,264 in 2020 after becoming Director. The vast majority of their compensation came in the form of option awards of $1,720,684 , and
What is R. Douglas Norby's' Mailing Address?
- Mailing address is C/o Magnachip Semiconductor, Inc. 20400 Stevens Creek Boulevard, Suite 370 Cupertino CA 95014 CA
Krystal Biotech, Inc Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Stock Awards
|
Option Awards
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|---|
| Krish S. Krishnan | 2020 | $498,220 | $254,153 | - | - | - | $752,373 |
| Krish S. Krishnan | 2019 | $365,725 | - | - | - | - | $365,725 |
| Suma M. Krishnan | 2020 | $392,215 | $140,054 | - | - | - | $532,269 |
| Suma M. Krishnan | 2019 | $305,642 | - | - | - | - | $305,642 |
| Kathryn A. Romano | 2020 | $190,580 | - | - | $1,720,684 | - | $1,911,264 |
| Kathryn A. Romano | 2019 | - | - | - | - | - | - |
| No matching records found | |||||||
Source: https://www.sec.gov/Archives/edgar/data/1711279/000119312521107627/d148315ddef14a.htm
What are Krystal Biotech, Inc's Past Insider Trades?
Krystal Biotech, Inc's most recent insider trade came on September 12, 2023 by Suma Krishnan who sold 50,000 units worth $6.36M . In the last 6 years, insiders at Krystal Biotech, Inc have sold an estimated value of $124.52M and bought an estimated value of $9.56M worth of shares. Insider trading is most common in July, with the busiest year in 2023. The most active traders at the company are Suma Krishnan, President, Krish S Krishnan, President and CEO, and Daniel Janney, Director .
Krystal Biotech, Inc. Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||